| Breakdown | Mar 2026 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.62B | 2.15B | 1.95B | 1.86B | 1.81B |
| Gross Profit | 1.27B | 2.00B | 1.66B | 884.30M | 874.30M |
| EBITDA | 1.59B | 1.19B | 992.70M | 1.19B | 1.16B |
| Net Income | 586.80M | 264.70M | 126.90M | -56.80M | 453.40M |
Balance Sheet | |||||
| Total Assets | 18.13B | 16.77B | 15.65B | 14.44B | 14.18B |
| Cash, Cash Equivalents and Short-Term Investments | 1.79B | 1.67B | 1.40B | 240.90M | 744.10M |
| Total Debt | 11.49B | 10.79B | 10.00B | 7.98B | 8.45B |
| Total Liabilities | 15.89B | 14.77B | 13.60B | 11.48B | 11.15B |
| Stockholders Equity | 2.24B | 2.00B | 2.06B | 2.96B | 3.03B |
Cash Flow | |||||
| Free Cash Flow | -110.20M | -79.90M | -19.00M | 305.90M | 221.80M |
| Operating Cash Flow | 1.38B | 918.10M | 745.10M | 934.40M | 865.80M |
| Investing Cash Flow | -1.48B | -987.20M | -731.40M | -639.70M | -555.70M |
| Financing Cash Flow | 221.40M | 358.80M | 1.04B | -809.70M | -89.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £63.57B | 21.31 | 7.66% | 4.15% | -9.52% | 35.74% | |
74 Outperform | £30.22B | 16.49 | 7.09% | 2.98% | 1.78% | -50.72% | |
71 Outperform | £9.43B | 8.54 | 17.64% | 4.50% | 10.68% | 35.18% | |
68 Neutral | £10.32B | 6.46 | 20.12% | 4.45% | 21.96% | 121.69% | |
67 Neutral | £2.54B | 9.64 | 3.09% | 6.56% | 19.50% | ― | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
59 Neutral | £9.07B | 2.73 | 1.68% | 2.86% | -2.11% | -104.48% |